Influenza Vaccine and COVID-19 Pandemic: Could This Vaccine Help Limit the Potential Adverse Consequences of SARS-CoV-2?

Mosaed, Reza; Fasihi, Hossein; Norouzi, Amir; Anjomanian, Vahid; Ardalan, Mohammad Afshar; Alazmani Noodeh, Farshid; Khoshdel, Ali Reza

Mosaed, Reza; Fasihi, Hossein; Norouzi, Amir; Anjomanian, Vahid; Ardalan, Mohammad Afshar; Alazmani Noodeh, Farshid; Khoshdel, Ali Reza.

Afiliación

Mosaed R; Department of Clinical Pharmacy, School of Medicine, AJA University of Medical Sciences, Tehran, Iran.
Fasihi H; Biomaterial and Medicinal Chemistry Research Center, AJA University of Medical Sciences, Tehran, Iran.
Norouzi A; Iran Armed Forces Health Insurance Organization, Tehran, Iran.
Anjomanian V; Iran Armed Forces Health Insurance Organization, Tehran, Iran.
Ardalan MA; Internal Medicine Department, School of Medicine, AJA University of Medical Sciences, Tehran, Iran.
Alazmani Noodeh F; Critical Care Nursing Department, Faculty of Nursing, Aja University of Medical Sciences, Tehran, Iran.
Khoshdel AR; Department of Public Health, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Iran J Pharm Res ; 21(1): e127032, 2022 Dec.

Article en En | MEDLINE | ID: mdl-36710988

Palabras clave

COVID-19; Influenza; Mortality; Pneumonia; Vaccine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Iran J Pharm Res Año: 2022 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google